Stock OSE OSE IMMUNOTHERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Revisions OSE Immunotherapeutics

Equities

OSE

FR0012127173

Market Closed - Euronext Paris
Other stock markets
 11:35:28 2024-04-26 am EDT 		5-day change 1st Jan Change
5.56 EUR -0.71% Intraday chart for OSE Immunotherapeutics +3.35% +29.91%
Apr. 17 OSE: licensing agreement with AbbVie enters into force CF
Apr. 17 OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. OSE Stock
  4. Revisions OSE Immunotherapeutics